Tech entrepreneurs and start-up founders Reid Hoffman (LinkedIn and PayPal) and Mark Pincus (Zynga) team up again with private investor Michael Thompson to create their third SPAC. The intended acquisition targets will include disruptive tech companies. (Blank check company incorporated in the Cayman Islands) (Reinvent Technology Partners Y priced its SPAC IPO on March 15, 2021, […]

We intend to focus our search on the restaurant, hospitality, and related sectors in North America. (Note: FAST Acquisition Corp. II priced its SPAC IPO on March 15, 2021, in line with the terms in its prospectus: 20 million units at $10 each to raise $200 million.)

We intend to capitalize on the ability of our management team to identify promising opportunities in the life sciences industry in Europe. (Blank check company incorporated in the Cayman Islands) (Note: European Biotech Acquisition priced its SPAC IPO on March 15, 2021, in sync with the terms in its prospectus: 10 million units at $10 […]

We intend to focus our efforts identifying businesses in technology, direct to consumer and FinTech industries. (Note: This new blank-check company is unusual in that its board chair, its CEO and its CFO are all women – at a time when most SPACs or blank-check companies are still run by men. This special-purpose acquisition company […]

We intend to search for a target business that provides critical resources and/or services to the technologies powering the 21st century industrial economy. Opportunities include, but are not limited to, suppliers or extractors of essential and scarce natural resources (such as lithium, nickel, aluminum, hydrogen, helium and cobalt), electrification and energy transition (such as fuel cells, […]

(Note: Leonardo DRS, Inc. withdrew its IPO plans in an SEC letter dated Sept. 29, 2022, noting the company decided not to proceed with the IPO, and had instead decided to enter into an all-stock merger with RADA Electronic Industries Ltd. Leonardo DRS had filed its S-1 for the IPO on Feb. 26, 2021. Its […]

Our mission is to build and enable the most trusted and efficient digital marketplaces for buying and selling used vehicles with transparency and comprehensive data that was previously unimaginable.  We provide a vibrant digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information to our customers. Our platform leverages […]

We are a clinical-stage biopharmaceutical company developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies to treat patients with cancer. We are advancing our lead TIL product candidate, ITIL-168, to treat advanced melanoma. We plan to submit an investigational new drug (IND) application to the U.S. Food and Drug Administration and, […]

We are a clinical-stage microbiome therapeutics company leveraging our Human-First Discovery platform to develop a novel class of orally administered biological drugs. The microbiome consists of trillions of microbes that live symbiotically in and on every human and are essential to our health. When key microbes are lost, the resulting dysbiosis can increase susceptibility to […]

We are a global clinical-stage biopharmaceutical company developing therapies for the treatment of T cell-driven inflammatory diseases. Our core expertise is in the use of functional cellular assays with T cells to screen and discover potent product candidates against immune targets. Our two most advanced clinical-stage programs include highly differentiated product candidates against validated targets. Our lead […]